US Stock MarketDetailed Quotes

RIGL Rigel Pharmaceuticals

Watchlist
  • 17.090
  • -0.120-0.70%
Close Dec 20 16:00 ET
  • 17.090
  • 0.0000.00%
Post 16:20 ET
301.04MMarket Cap63.30P/E (TTM)

About Rigel Pharmaceuticals Company

Rigel Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. It discovers and develops novel, targeted drugs in the therapeutic areas of immunology, oncology and immune oncology. The firm focuses on intracellular signalling pathways and related targets that are critical to disease mechanisms. The company's products include Tavalisse, Fostamatinib and R835. Rigel Pharmaceuticals was founded by Donald G. Payan, James M. Gower, Thomas A. Raffin, Garry P. Nolan and Ronald B. Garren on June 14, 1996 and is headquartered in South San Francisco, CA.

Company Profile

SymbolRIGL
Company NameRigel Pharmaceuticals
Listing DateNov 29, 2000
Issue Price7.00
Founded1996
CEOMr. Raul R. Rodriguez
MarketNASDAQ
Employees147
Fiscal Year Ends12-31
Address611 Gateway Boulevard,Suite 900
CitySouth San Francisco
ProvinceCalifornia
CountryUnited States of America
Zip Code94080-1985
Phone1-650-624-1100
Websitehttp://www.rigel.com

Company Executives

  • Name
  • Position
  • Salary
  • Raul R. Rodriguez
  • Director, President and Chief Executive Officer
  • 3.44M
  • Raymond J. Furey
  • Executive Vice President, General Counsel, Chief Compliance Officer and Corporate Secretary
  • 683.00K
  • Dean L. Schorno
  • Executive Vice President and Chief Financial Officer
  • 1.21M
  • David A. Santos
  • Executive Vice President and Chief Commercial Officer
  • 1.34M
  • Gregg Anthony Lapointe, C.P.A.,M.B.A.
  • Chairman of the Board
  • 190.58K
  • Kamil Ali-Jackson, Esq.
  • Independent Director
  • 140.58K
  • Jane Wasman, J.D.
  • Independent Director
  • 145.58K
  • Dr. Walter H. Moos,PhD
  • Independent Director
  • 138.58K
  • Dr. Alison L. Hannah, M.D.
  • Independent Director
  • 212.98K
Heat List
US
Overall
Symbol
Price
% Chg

No Data